Study to Test the Efficacy and Safety of YM178 in Subjects With Symptoms of Overactive Bladder (Blossom)

This study has been completed.

Sponsor:

Information provided by (Responsible Party):

Astellas Pharma Inc ( Astellas Pharma Europe BV )

ClinicalTrials.gov Identifier:

NCT01604928

First received: May 22, 2012

Last updated: NA

Last verified: May 2012

History: No changes posted

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	January 2005
Primary Completion Date:	January 2005 (Final data collection date for primary outcome measure)